Data-driven medicine: understanding the link between genetics and disease

| | October 17, 2013
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

From Google to Facebook and GCHQ to the NSA, every day we hear more about the lengths to which organizations are going to get their hands on our precious data.

Retail, advertising, manufacturing, transport, energy, local government, charity – whichever sector you care to look at, data is playing an increasingly important role in our society and economy. While many people view this as an invasion of their privacy, the majority of this data is anonymous and contributes to genuinely valuable research.

The Wellcome Sanger Institute, which was the single largest contributor to the Human Genome Project, is now using so-called ‘big data’ to investigate the genetic make-up of some of the most common causes of premature death.

Read the full, original story here: Data-driven medicine: understanding the link between genetics and disease

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend